"Example:\nSentence: \"Co-administration of single 25-mg dose warfarin had no effect on the pharmacokinetics of total lenalidomide.\"\nEntities: lenalidomide, warfarin\nTriplets:\n(warfarin, no interaction, lenalidomide)\n\nExample:\nSentence: \"- Methyldopa (e.g., Aldomet) Use of methyldopa with sulfapyridine may increase the chance of side effects affecting the liver and/or the blood\"\nEntities: Aldomet, Methyldopa, methyldopa, sulfapyridine\nTriplets:\n(Methyldopa, no interaction, Aldomet)\n(Methyldopa, no interaction, methyldopa)\n(Methyldopa, no interaction, sulfapyridine)\n(Aldomet, no interaction, methyldopa)\n(Aldomet, no interaction, sulfapyridine)\n(methyldopa, effect, sulfapyridine)\n\nExample:\nSentence: \"Methotrexate VIOXX 12.5, 25, and 50 mg, each dose administered once daily for 7 days, had no effect on the plasma concentration of methotrexate as measured by AUC0-24hr in patients receiving single weekly methotrexate doses of 7.5 to 20 mg for rheumatoid arthritis.\"\nEntities: Methotrexate, VIOXX, methotrexate\nTriplets:\n(Methotrexate, no interaction, VIOXX)\n(Methotrexate, no interaction, methotrexate)\n(Methotrexate, no interaction, methotrexate)\n(VIOXX, no interaction, methotrexate)\n(VIOXX, no interaction, methotrexate)\n(methotrexate, no interaction, methotrexate)\n\nExample:\nSentence: \"The emerging roles of non-nucleoside reverse transcriptase inhibitors in antiretroviral therapy.\"\nEntities: antiretroviral, non-nucleoside reverse transcriptase inhibitors\nTriplets:\n(non-nucleoside reverse transcriptase inhibitors, no interaction, antiretroviral)\n\nExample:\nSentence: \"Acetazolamide and sodium bicarbonate used concurrently increases the risk of renal calculus formation.\"\nEntities: Acetazolamide, sodium bicarbonate\nTriplets:\n(Acetazolamide, effect, sodium bicarbonate)\n"